Medication info
Mediroten Tablet 5/80 mg (Amlodipine Besilate, Valsartan)

Mediroten Tablet 5/80 mg (Amlodipine Besilate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›80mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 201308476 · Approved 2013.07.30 · Insurance code 646003730

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Amlodipine or Valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during the second or third trimester of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this drug or similar medications, pregnant or breastfeeding women, patients with severe kidney or liver diseases, and those with certain heart diseases should not take this drug. Patients with low sodium or body fluid levels should correct their condition before taking this medication, and careful monitoring is needed as hypotension may occur during treatment. Patients with elevated potassium levels should frequently check their potassium levels when taking this medication along with drugs that can increase potassium. Patients with renal vascular abnormalities or those who have received kidney transplants should use this medication cautiously, as renal function may decline. If vascular edema occurs during treatment with this drug, administration should be stopped immediately and not restarted. Patients with heart failure or those recovering from myocardial infarction should regularly monitor kidney function and blood pressure while taking this medication, with particular caution for patients with severe heart failure. Patients with acute myocardial infarction or certain heart valve diseases should be cautious, as symptoms may worsen while taking this medication. It is not recommended to take this medication along with other drugs that act on the renin-angiotensin-aldosterone system. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. In case of overdose, severe hypotension or cardiac abnormalities may occur, requiring immediate contact with a medical institution and, if necessary, suitable emergency treatment. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been sufficiently established. Elderly patients may use the same dose as adults, but careful monitoring considering their physical condition is required. During the treatment with this medication, regular checks for blood pressure, kidney function, electrolyte levels, etc., should be performed to identify any abnormalities. Women who are pregnant or planning to become pregnant must consult a doctor, and breastfeeding women are advised to avoid taking this medication.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional vertigo, paresthesia, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, including hypersensitivity with serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste abnormalities, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin discoloration, photosensitivity reactions, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, voiding disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervous irritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, nervous irritability, sensory loss, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity; therefore, it should be stored in a tightly closed container. Avoid storing in extremely hot or cold places, and it is advisable to keep it at room temperature between 1 degrees and 30 degrees.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.